Détail - canceropole-wordpress

Comments on Optimizing TULSA for Localized Prostate 1 Cancer: Lessons from Functional and Imaging Outcomes.

Tricard T, Cazzato RL

J Vasc Interv Radiol. 2025 10 27;:

The surgeon's assessment of endoscopic image quality is not reliable: a prospective pilot study.

Tricard T, Comeau D, Lott C, Huesch T, Gaillard V

Fr J Urol. 2025 10 16;:103008

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer (MRI-TULSA): A Prospective Trial.

Tricard T, Cazzato RL, Schroeder A, De Mathelin M, Barhoumi C, Gaillard V, Sauleau E, Gangi A, Lang H

J Vasc Interv Radiol. 2025 05 27;:

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Blanc J, Carnot A, Barthélémy P, Casert V, Sautois B, Van den Brande J, Vanhaudenarde V, Staudacher L, Seront E, Debien V, Ameye L, Kotecki N, Rothé F, Rorive S, Fantoni JC, Tricard T, Roumeguère T, Awada A, Martinez Chanza N

J Immunother Cancer. 2025 05 24;13(5):

Transperineal MRI-guided Prostate Biopsy: A Prospective Randomized Controlled Study on Safety and Efficacy.

Tricard T, Cazzato RL, Poussot B, Gaillard V, Labani A, De Mathelin M, Barhoumi C, Sauleau E, Gangi A, Roy C, Lang H

J Vasc Interv Radiol. 2025 05 17;:

Concordance with radical prostatectomy specimen of in-bore MRI-guided transperineal vs US-guided transrectal prostate biopsies: a propensity score matched analysis.

Poussot B, Gaillard V, Cazzato RL, Roy C, Gangi A, Tricard T, Lang H

Fr J Urol. 2025 05 15;:102907

TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma.

Helleux A, Davidson G, Lallement A, Hourani FA, Haller A, Michel I, Fadloun A, Thibault-Carpentier C, Su X, Lindner V, Tricard T, Lang H, Tannir NM, Davidson I, Malouf GG

EMBO Mol Med. 2025 03 27;:

Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.

Peyrottes A, Baboudjian M, Diamand R, Ducrot Q, Vitard C, Baudewyns A, Windisch O, Anract J, Dariane C, Tricard T, Sarkis J, Sadreux Y, Oderda M, Depaquit TL, La Taille A, Olivier J, Brureau L, Rouviere O, Crouzet S, Ruffion A, Desgrandchamps F, Roumiguie M, Rouprêt M, Ploussard G, Fiard G,

Eur Urol Oncol. 2025 02 17;:

Collecting Duct Carcinoma: Characteristics and Survival Outcomes From UroCCR Database (CDCSurv UroCCR n°141).

Le Mével LP, Bernhard JC, Yacoub M, Waeckel T, Bazille C, Champy C, Mamodaly M, Bensalah K, Rioux-Leclercq N, Michel C, Hergli I, Surlemont L, Leclerc J, Roupret M, Bruyere F, Fromont G, Tricard T, Lindner V, Parier B, Ferlicot S, Hermieu JF, Bucau M, Pettenati C, Lebdai S, Culty T, Nedelcu C, Zidane-Marinnes M, Bigot P

Clin Genitourin Cancer. 2025 01 23;23(2):102305

Profile and methodology of ancillary protective measures employed during percutaneous renal cryoablation in a single high-volume centre.

Orkut S, De Marini P, Tan ASM, Garnon J, Koch G, Tricard T, Lang H, Cazzato RL, Gangi A

Radiol Med. 2025 01 20;:

Impact of antibiotic treatment duration for preoperative asymptomatic bacteriuria, during urological surgery, on postoperative infectious complications: results from the multicentric TOCUS cohort.

Robin H, Kutchukian S, Bigot P, Françot M, de Vergie S, Rigaud J, Chapuis M, Brureau L, Jousseaume C, Karray O, Kosseifi FT, Descazeaud A, Asare HJ, Gaullier M, Poussot B, Tricard T, Borojeni S, Gondran-Tellier B, Baboudjian M, Lechevallier É, Delpech PO, Ayoub E, Ducousso H, Bernardeau S, Dinh A, Bruyère F, Vallée M

Minerva Urol Nephrol. 2024 11 28;:

Validation of the Objective Structured assessment of Technical Skill (OSATS) in China.

Tricard T, Pan J, Song Q, Lu Y, Ye G, Bian Z

J Surg Educ. 2024 11 9;82(1):103304

Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129.

Martini A, Bernhard JC, Falagario UG, Herman G, Geshkovska A, Khene ZE, Audenet F, Champy C, Bruyere F, Rolland M, Waeckel T, Lorette M, Doumerc N, Surlemont L, Parier B, Tricard T, Branger N, Michel C, Fiard G, Fontenil A, Vallée M, Guillotreau J, Patard JJ, Joncour C, Boissier R, Ouzaid I, Panthier F, Belas O, Mallet R, Gimel P, DE Vergie S, Bigot P, Beauval JB

Minerva Urol Nephrol. 2024 10;76(5):578-587

Conservative management of inferior vena cava thrombus during nephrectomy for renal cell carcinoma.

Gaillard V, Tricard T, Addeo P, Aussenac-Belle L, Poussot B, Lindner V, Lang H

Urol Oncol. 2024 09 14;:

Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study.

Su R, Huang T, Gu L, Bao Y, Liu Z, Dao P, Yao L, Hu X, Fu G, Wu J, Tricard T, Wu G, Chen M, Li C, Huang Z, Zheng B, Chen Y, Xue W, Guo G, Dong P, Huang J, Zhang J

Cancer Med. 2024 09;13(17):e70181

Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial.

Huang J, Wang Y, Xu F, Wang Z, Wu G, Kong W, Cheoklong NG, Tricard T, Wu X, Zhai W, Zhang W, Zhang J, Zhang D, Chen S, Lian Y, Chen Y, Zhang J, Huang Y, Xue W

J Immunother Cancer. 2024 06 11;12(6):

Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas.

Moinard-Butot F, Oriel M, Tricard T, Cazzato RL, Pierard L, Gaillard V, Werle P, Lindner V, Martin S, Schuster C, Roy C, Burgy M, Anthony A, Bigot C, Boudier P, Fritsch A, Olland A, Malouf G, Lang H, Barthélémy P

Clin Genitourin Cancer. 2024 06 5;22(5):102134

Risk Factors for Artificial Urinary Sphincter Explantation and Erosion in Male Nonneurological Patients.

Pitout A, Lecoanet P, Mazeaud C, Gaillard V, Poussot B, Tricard T, Saussine C, Brierre T, Game X, Beraud F, Biardeau X, Bruyere F, Robin D, El-Akri M, Chevallier D, Cousin T, Capon G, Cornu JN, Dupuis H, Monsaint H, Hermieu N, Hermieu JF, Léon P, Peyronnet B, Bentellis I

Int Neurourol J. 2024 06;28(2):147-155

Asymptomatic Bacteriuria and Urological Surgery: Risk Factor or Not? Results from the National and Multicenter TOCUS Database.

Kutchukian S, Gondran-Tellier B, Dinh A, Robin H, Bigot P, Françot M, de Vergie S, Rigaud J, Chapuis M, Brureau L, Jousseaume C, Karray O, Kosseifi FT, Borojeni S, Descazeaud A, Chicaud M, Asare HJ, Gaullier M, Poussot B, Tricard T, Baboudjian M, Lechevallier É, Delpech PO, Ayoub E, Héloïse Ducousso H, Bernardeau S, Bruyère F, Vallée M

J Urol. 2024 05 16;:101097JU0000000000004047

A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

Qian H, Chi C, Tricard T, Zhu Y, Dong L, Wang Y, Sha J, Wang J, Ma Z, Wang Y, Liu J, Dong B, Pan J, Xue W

J Urol. 2024 05;211(5):648-655

[Short-term functional outcomes of laparoscopic robotic-assisted cystectomy (RAC) with ileal conduit urinary diversion (ICUD) for lower urinary tract dysfunction (LUTD): a single-center retrospective study.].

Tomos G, Saussine C, Gaillard V, Lang H, Tricard T

Fr J Urol. 2024 04 16;:102639

The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study.

Fleury R, Bertail T, Bensalah K, Bernhard JC, Audenet F, Waeckel T, Parier B, Champy C, Olivier J, Doumerc N, Tricard T, Branger N, Bruyere F, Neuville P, Surlemont L, Alexandre Long J, Fontenil A, Vallee M, Roupret M, Boissier R, Jacques Patard J, Durand M, Ouzaid I, Rouget B, Durand X, Joncour C, Belas O, Denise Gomez F, Bigot P, Khene ZE,

Eur Urol Open Sci. 2024 04;62:123-130

Asymptomatic bacteriuria prior to partial and radical nephrectomy: To screen or not to screen? Results from the national and multicenter TOCUS database.

Ayoub E, Kutchukian S, Bigot P, Dinh A, Gondran-Tellier B, Robin H, Françot M, de Vergie S, Rigaud J, Chapuis M, Brureau L, Jousseaume C, Karray O, Kosseifi FT, Borojeni S, Descazeaud A, Asare HJ, Gaullier M, Poussot B, Tricard T, Baboudjian M, Lechevallier É, Delpech PO, Ducousso H, Bernardeau S, Bruyère F, Vallée M

World J Urol. 2024 03 20;42(1):179

MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.

Fung KFK, Cazzato RL, Tricard T, Marini PDE, Bertucci G, Autrusseau PA, Koch G, Weiss J, Garnon J, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2024 03 15;:

Performance of a Region of Interest-based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database-CAD-FIRST Study.

Couchoux T, Jaouen T, Melodelima-Gonindard C, Baseilhac P, Branchu A, Arfi N, Aziza R, Barry Delongchamps N, Bladou F, Bratan F, Brunelle S, Colin P, Correas JM, Cornud F, Descotes JL, Eschwege P, Fiard G, Guillaume B, Grange R, Grenier N, Lang H, Lefèvre F, Malavaud B, Marcelin C, Moldovan PC, Mottet N, Mozer P, Potiron E, Portalez D, Puech P, Renard-Penna R, Roumiguié M, Roy C, Timsit MO, Tricard T, Villers A, Walz J, Debeer S, Mansuy A, Mège-Lechevallier F, Decaussin-Petrucci M, Badet L, Colombel M, Ruffion A, Crouzet S, Rabilloud M, Souchon R, Rouvière O

Eur Urol Oncol. 2024 03 15;:

ASO Visual Abstract: Retroperitoneoscopic Clampless Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors.

Wu X, Zhou J, Chen W, Cai W, Liu D, Huang Y, Tricard T, Chen Y, Xue W

Ann Surg Oncol. 2023 11 2;:

Retroperitoneoscopic Clampless, Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors.

Wu X, Zhou J, Chen W, Cai W, Liu D, Huang Y, Tricard T, Chen Y, Xue W

Ann Surg Oncol. 2023 10 30;:

Which revision strategy is the best for non-mechanical failure of male artificial urinary sphincter?

Cousin T, Peyronnet B, Bentellis I, Lasri S, Taha F, Hermieu N, Boileau A, Zelmar A, Ciolek C, Dubois A, Leon P, Hermieu JF, Brierre T, Gamé X, Tricard T, Saussine C, Lecoanet P, Vidart A, Bruyère F, Cornu JN, Monsaint H, Biardeau X, Capon G

World J Urol. 2023 10 30;:

Nephrometry scores to predict oncological outcomes following partial nephrectomy (UroCCR Study 70).

Lorette M, Bernhard JC, Bensalah CK, Bigot P, Villers A, Letouche ML, Doumerc N, Paparel P, Audenet F, Nouhaud FX, Parier B, Tricard T, Champy C, Brenier M, Pignot G, Long JA, Durand M, Vallee M, Waeckel T, Boissier R, Tambwe R, Ouzaid I, Olivier J, Khene ZE,

World J Urol. 2023 10 4;:

Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of Urology.

Nasri J, Al Ashimi I, Tricard T, Fleury R, Matta I, Bey E, Mesnard B, Gaillet S, Martin C, Game X, Thuillier C, Chartier-Kastler E, Karsenty G, Perrouin-Verbe MA, Demeestere A, Wagner L, Ruffion A, Peyronnet B, Saussine C, Phé V, Vermersch P, De Wachter S, Biardeau X

World J Urol. 2023 10 2;:

Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation.

Lehrer R, Cornelis F, Bernhard JC, Bigot P, Champy C, Bruyère F, Rouprêt M, Doumerc N, Bensalah CK, Olivier J, Audenet F, Tricard T, Parier B, Durand X, Durand M, Charles T, Branger N, Surlemont L, Xylinas E, Beauval JB, Barral M

Eur Radiol. 2023 07 19;:

Efficacy, Safety, and Reoperation-free Survival of Artificial Urinary Sphincter in Non-neurological Male Patients over 75 Years of Age.

Girard C, El-Akri M, Durand M, Guérin O, Cornu JN, Brierre T, Cousin T, Gaillard V, Dupuis H, Tricard T, Hermieu N, Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Rambaud C, Peyronnet B, Bentellis I

Eur Urol Open Sci. 2023 07;53:23-30

Outcomes of holmium laser enucleation of the prostate (HoLEP) for very large-sized benign prostatic hyperplasia (over 150 mL): open simple prostatectomy is dead.

Tricard T, Xia S, Xiao D, Tong Z, Gaillard V, Sun J

World J Urol. 2023 07 1;:

Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear-cell renal cell carcinoma.

Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, Elaidi RT, Verkarre V, Sun CM, Chevreau C, Bennamoun M, Lang H, Tricard T, Fridman WH, Sautes-Fridman C, Su X, Plassard D, Keime C, Thibault-Carpentier C, Barthélémy P, Oudard SM, Davidson I, Malouf GG

Cancer Res. 2023 06 19;:

Adjustable continence therapy (proACT) for the treatment of male stress urinary incontinence post-prostatectomy: a systematic review and meta-analysis (2023 update).

Tricard T, Song QX, Munier P, Li JY, Leng J, Saussine C, Pan JH, Xue W

World J Urol. 2023 06 13;:

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, Gantzer J, Thouvenin J, Baltzinger P, Bouarich R, Manriquez V, Zaidi S, Rao P, Msaouel P, Su X, Lang H, Tricard T, Lindner V, Surdez D, Kurtz JE, Bourdeaut F, Tannir NM, Davidson I, Malouf GG

Nat Commun. 2023 05 26;14(1):3034

Robot-assisted vesicovaginal fistula repair: comparison of the extravesical and transvesical techniques.

Lecoanet P, Madanelo M, Tricard T, Mauger de Varennes A, Haudebert C, Richard C, Hascoet J, Bentellis I, Tibi B, Saussine C, Hubert J, Peyronnet B

Int Urogynecol J. 2023 05 19;:

Sacral neuromodulation in the management of non-obstructive urinary retention: Test phase and predictive factors.

Al Hashimi I, Saussine C, Tricard T

Prog Urol. 2022 11 16;:

An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas.

Lu X, Vano Y, Helleux A, Su X, Lindner V, Davidson G, Mouawad R, Spano JP, Roupret M, Elaidi R, Compérat E, Verkarre V, Sun C, Chevreau C, Bennamoun M, Lang H, Tricard T, Cheng W, Xu L, Davidson I, Yan F, Fridman WH, Sautes-Fridman C, Oudard S, Malouf GG

Clin Cancer Res. 2022 11 14;:

Analysing the learning curve of prostate enucleation with the Holmium laser: A retrospective, single-centre experience.

Sie M, Saussine C, Munier P, Tricard T

Prog Urol. 2022 07 6;:

[Bladder pain syndrome: Long-term results (15 years) of a single-center experience].

De Cian M, Tricard T, Saussine C

Prog Urol. 2022 06 10;:

Primary care-based follow-up for prostate and kidney cancer survivors: a retrospective monocentric study.

Gaillard V, Tricard T, Rebel S, Schumacher C, Saussine C, Somme G, Lang H

Support Care Cancer. 2022 05 23;:

Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.

Gaillard V, Lhuillier A, Bigot C, Pierard L, Trensz P, Burgy M, Schuster C, Malouf G, Fritsch A, Lang H, Tricard T, Borchiellini D, Geoffrois L, Barthelemy P

Support Care Cancer. 2022 Apr 29;:

Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.

Vano YA, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B, Barthélémy P, Coquan E, Gravis G, Houede N, Cancel M, Huillard O, Beuzeboc P, Fournier L, Méjean A, Cathelineau X, Doumerc N, Paparel P, Bernhard JC, de la Taille A, Bensalah K, Tricard T, Waeckel T, Pignot G, Braychenko E, Caruso S, Sun CM, Verkarre V, Lacroix G, Moreira M, Meylan M, Bougouïn A, Phan L, Thibault-Carpentier C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C, Oudard S

Lancet Oncol. 2022 Apr 4;:

Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.

Rossi J, Cazzato RL, de Marini P, Auloge P, Autrusseau PA, Dalili D, Tricard T, Poussot B, Garnon J, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2022 Mar 10;:

[Artificial urinary sphincter in patients with urinary incontinence after High Intensity Focused ultrasound].

Robin D, Peyronnet B, Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Poussot B, Dupuis H, Tricard T, Hermieu N, Pitout A, Beraud F, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Hermieu JF, Lecoanet P, Capon G, Saussine C, Gamé X, Léon P

Prog Urol. 2022 Feb 4;:

[Voiding dysfunction after TVT: A 20-year experience TVT-placement under local anesthesia and sedation].

Schmitt M, Tricard T, Saussine C

Prog Urol. 2021 Dec 13;:

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Martinez Chanza N, Soukane L, Barthelemy P, Carnot A, Gil T, Casert V, Vanhaudenarde V, Sautois B, Staudacher L, Van den Brande J, Culine S, Seront E, Gizzi M, Albisinni S, Tricard T, Fantoni JC, Paesmans M, Caparica R, Roumeguere T, Awada A

BMC Cancer. 2021 Dec 2;21(1):1292

Impact of radiation therapy on artificial urinary sphincter implantation in male patients: A multicenter study.

Mamane J, Sanchez S, Lellouch AG, Gaillard V, Poussot B, Tricard T, Saussine C, Brierre T, Game X, Beraud F, Biardeau X, Bruyere F, Robin D, El-Akri M, Chevallier D, Durand M, Bentellis I, Cousin T, Capon G, Cornu JN, Dupuis H, Monsaint H, Corbel L, Hermieu N, Hermieu JF, Pitout A, Lecoanet P, Peyronnet B, Leon P

Neurourol Urodyn. 2021 Nov 24;:

Early Efficacy and Safety Outcomes of Artificial Urinary Sphincter for Stress Urinary Incontinence Following Radical Prostatectomy or Benign Prostatic Obstruction Surgery: Results of a Large Multicentric Study.

Dupuis HGA, Bentellis I, El-Akri M, Brierre T, Cousin T, Gaillard V, Poussot B, Tricard T, Hermieu N, Robin D, Pitout A, Beraud F, Durand M, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Leon P, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Peyronnet B, Cornu JN

Eur Urol Focus. 2021 Sep 18;:

Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra.

El-Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Gaillard V, Poussot B, Robin D, Pitout A, Beraud F, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Saussine C, Hermieu JF, Lecoanet P, Capon G, Cornu JN, Game X, Ruffion A, Peyronnet B

World J Urol. 2021 Jul 17;:

Prevalence and Risk Factors of Artificial Urinary Sphincter Revision in Non-Neurological Male Patients.

Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Dupuis H, Tricard T, Hermieu N, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B

J Urol. 2021 Jun 29;:101097JU0000000000001954

Evaluation of the female bladder neck and urethra using MRI with fiber tractography: Prospective study on a large cohort of continent women.

Roy C, Ohana M, Labani A, Tricard T, Saussine C, Leyendecker P

Neurourol Urodyn. 2021 May 26;:

Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.

De Marini P, Cazzato RL, Garnon J, Dalili D, Leonard-Lorant I, Leclerc L, Autrusseau PA, Auloge P, Weiss J, Tricard T, Lang H, Gangi A

Diagn Interv Imaging. 2021 Apr 27;:

Real-life outcomes after artificial urinary sphincter explantation in women suffering from severe stress incontinence.

Tricard T, Al Hashimi I, Schroeder A, Munier P, Saussine C

World J Urol. 2021 Apr 9;:

Robot-assisted cystectomy and ileal conduit for neurogenic bladder : comparison of extracorporeal vs intracorporeal urinary diversion.

Mazouin C, Hubert J, Tricard T, Lecoanet P, Haudebert C, Bentellis I, Baron P, Hascoët J, Castes C, Verhoest G, Tibi B, Pradere B, Bruyere F, Capon G, Manunta A, Saussine C, Peyronnet B

J Endourol. 2021 Jan 26;:

Outcomes of laparoscopic artificial urinary sphincter in women with stress urinary incontinence: mid-term evaluation.

Schroeder A, Munier P, Saussine C, Tricard T

World J Urol. 2021 Jan 2;:

Lecoanet P, Mauger De Varennes A, Mazouin C, Manunta A, Hubert N, Tricard T, Bentellis I, Durand M, Hascoet J, Hubert J, Peyronnet B

Prog Urol. 2020 Nov;30(13):761-762

Brierre T, Tricard T, Bentelis I, El-Akri M, Cousin T, Dupuis H, Hermieu N, Poussot B, Pitou A, Bertrand-Leon P, Chevallier D, Bruyère F, Saussine C, Hermieux J, Lecoanet P, Ruffion A, Capon G, Cornu JN, Peyronnet B, Gamé X

Prog Urol. 2020 Nov;30(13):778

El-Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Depuis H, Hermieu N, Robin D, Poussot B, Bertrand P, Chevallier D, Bruyère F, Saussine C, Lecoanet P, Capon G, Hermieu J, Cornu JN, Gamé X, Ruffion A, Peyronnet B

Prog Urol. 2020 Nov;30(13):779

Bentellis I, El-Akri M, Tricard T, Briere T, Cousin T, Dupuis H, Hermieu N, Gailèard V, Ruffion A, Bertrand-Léon P, Chevallier D, Corbel L, Bruyère F, Saussine C, Hermieu J, Lecouanet P, Capon G, Cornu JN, Gamé X, Peyronnet B

Prog Urol. 2020 Nov;30(13):779-780

Bentellis I, El-Akri M, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Poussot B, Pitout A, Bertrand-Léon P, Chevallier D, Bruyère F, Saussine C, Hermieu J, Lecouanet P, Ruffion A, Capon G, Cornu JN, Gamé X, Peyronnet B

Prog Urol. 2020 Nov;30(13):782-783

El-Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Robin D, Gaillard V, Bertrand-Léon P, Chevallier D, Bruyère F, Saussine C, Hermieu J, Lecoanet P, Capon G, Cornu JN, Gamé X, Ruffion A, Peyronnet B

Prog Urol. 2020 Nov;30(13):783-784

Gaillard V, Tricard T, Garnon J, Cazzato R, Gangi A, Lang H

Prog Urol. 2020 Nov;30(13):788

Mazouin C, Lecoanet P, Tricard T, Baron P, Bentellis I, Haudebert C, Hascoet J, Dosin G, Tibi B, Pradère B, Bruyère F, Manunta A, Saussine C, Hubert J, Peyronnet B

Prog Urol. 2020 Nov;30(13):802-803

Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.

Cazzato RL, De Marini P, Leonard-Lorant I, Leclerc L, Auloge P, Tricard T, Dalili D, Garnon J, Lang H, Gangi A

Invest Radiol. 2020 Sep 4;:

Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.

Cazzato RL, De Marini P, Auloge P, Leclerc L, Tricard T, Linder V, Jost M, Ramamurthy N, Lang H, Garnon J, Gangi A

Eur Radiol. 2020 Aug 27;:

Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.

Gaillard V, Tricard T, Garnon J, Cazzato RL, Dalili D, Gangi A, Lang H

Urol. Oncol.. 2020 Aug 7;:

Pregnancy and Delivery in Women with Lower Urinary Tract Reconstruction: A National Multicenter Retrospective Study.

Bey E, Manach Q, Peyronnet B, Even A, Chartier Kastler E, Walder R, Ruffion A, Baron M, Charlanes A, Biardeau X, Quenneville V, Boillot B, Duport C, Tricard T, Saussine C, Gamé X, Capon G, Kerdraon J, Cornu JN, Garabedian C, Le Normand L, Perrouin-Verbe B, Phe V, Perrouin-Verbe MA

J. Urol.. 2020 Jul 2;:101097JU0000000000001233

The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.

Metzger-Peter K, Kremer LD, Edan G, Loureiro De Sousa P, Lamy J, Bagnard D, Mensah-Nyagan AG, Tricard T, Mathey G, Debouverie M, Berger E, Kerbrat A, Meyer N, De Seze J, Collongues N

Trials. 2020 Jun 29;21(1):591